Lapatinib In Combination With Chemotherapy In Subjects With Relapsed Breast Cancer

NCT00479856 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

9

Enrollment

INDUSTRY

Sponsor class

Stopped Study was terminated due to difficulty in identifying eligible subjects

Conditions

Relapsed Breast Cancer
Neoplasms, Breast

Interventions

DRUG: Lapatinib
DRUG: Capecitabine
DRUG: Docetaxel
DRUG: nab-Paclitaxel

Sponsor

GlaxoSmithKline